National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 23053 [2020-08682]
Download as PDF
Federal Register / Vol. 85, No. 80 / Friday, April 24, 2020 / Notices
Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 which was
published in the Federal Register on
December 06, 2019, 84 FR 66922.
This notice is being amended to
change the meeting date, time, location
and contact person from May 26–27,
2020, 3:00 p.m. to 12:45 p.m., National
Institutes of Health, Natcher Building,
45 Center Drive, Bethesda, MD 20892 to
May 26, 2020, 1:00 p.m. to 5:00 p.m., a
virtual meeting.
Contact Person: Kenneth Santora,
Ph.D., Director, Office of Extramural
Activities, National Institute on Aging,
National Institutes of Health, Gateway
Building, 7201 Wisconsin Avenue,
Bethesda, MD 20814, (301) 496–9322,
ksantora@nih.gov. Any member of the
public may submit written comments no
later than 15 days after the meeting.
Dated: April 21, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08778 Filed 4–23–20; 8:45 am]
Health, 6701 Democracy Boulevard, Suite
664 Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Dental and
Craniofacial Research, National Institutes of
Health, 6701 Democracy Boulevard, Suite
664, Bethesda, MD 20892, 301–402–8559
jimok.kim@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: April 20, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08682 Filed 4–23–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
BILLING CODE 4140–01–P
AGENCY:
National Institutes of Health,
HHS.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ACTION:
Notice.
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on April
30, 2020. The topic for this meeting will
be ‘‘Improving Cardiovascular
Outcomes in People with Type 1
Diabetes.’’ The meeting is open to the
public.
SUMMARY:
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; NIDCR R35 Award Review.
Date: June 4, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, National Institutes of
VerDate Sep<11>2014
17:03 Apr 23, 2020
Jkt 250001
The meeting will be held on
April 30, 2020 from noon to 3:00 p.m.
ADDRESSES: The meeting will be held
via videoconference. For details, and to
register, please contact dmicc@
mail.nih.gov.
DATES:
For
further information concerning this
meeting, including a draft agenda, see
the DMICC website,
www.diabetescommittee.gov, or contact
Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; FAX:
301–480–6741; email: dmicc@
mail.nih.gov.
FOR FURTHER INFORMATION CONTACT:
In
accordance, with 42 U.S. Code
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
23053
§ 202F;285c–3, the DMICC, chaired by
the National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK)
comprising members of the Department
of Health and Human Services and other
federal agencies that support diabetesrelated activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
April 30, 2020 DMICC meeting will
focus on ‘‘Improving Cardiovascular
Outcomes in People with Type 1
Diabetes.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 5
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
website, www.diabetescommittee.gov.
Dated: April 20, 2020.
Bruce T. Roberts,
Executive Secretary, DMICC, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2020–08685 Filed 4–23–20; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\24APN1.SGM
24APN1
Agencies
[Federal Register Volume 85, Number 80 (Friday, April 24, 2020)]
[Notices]
[Page 23053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08682]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; NIDCR R35 Award Review.
Date: June 4, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
National Institutes of Health, 6701 Democracy Boulevard, Suite 664
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Dental and
Craniofacial Research, National Institutes of Health, 6701 Democracy
Boulevard, Suite 664, Bethesda, MD 20892, 301-402-8559
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: April 20, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-08682 Filed 4-23-20; 8:45 am]
BILLING CODE 4140-01-P